Stratec Se

Stratec Se Cash Conversion Cycle

The Cash Conversion Cycle (CCC) of Stratec Se (SBS.DE) as of Nov 4, 2026 is 196.64. In the previous year, Cash Conversion Cycle (CCC) was 260.36 — a change of -24.47% (lower).

Cash Conversion Cycle

196.64

YoY

-24.47%

Last updated:

Cash Conversion Cycle (CCC) of Stratec Se is 2025 196.64 . Cash Conversion Cycle (CCC) of Stratec Se was 2024 260.36 . It decreases by -24.47% lower compared to the previous year.

The Stratec Se Cash Conversion Cycle history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion Cycle
Date
Cash Conversion Cycle
Jan 1, 2018
196.38 EUR
Jan 1, 2019
158.17 EUR
Jan 1, 2020
175.34 EUR
Jan 1, 2021
193.84 EUR
Jan 1, 2022
276.58 EUR
Jan 1, 2023
310.67 EUR
Jan 1, 2024
260.36 EUR
Jan 1, 2025
196.64 EUR
The Stratec Se Cash Conversion Cycle history
YEARCash Conversion CycleYoY
196.64-24.47%
260.36-16.20%
310.67+12.32%
276.58+42.68%
193.84+10.55%
175.34+10.86%
158.17-19.46%
196.38+61.18%
121.84-4.35%
127.38+16.06%
109.75+6.05%
103.49—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Stratec Se Stock analysis

What does Stratec Se do? The company Stratec SE is a German company operating in the medical technology industry. It was founded in 1984 and has since become a leading provider of automation solutions and diagnostic instruments. Stratec's business model is based on the development and production of devices and systems used in medical diagnostics. The company focuses in particular on the areas of immunology, clinical chemistry, and hematology. Stratec also offers innovative solutions in microscopy and cell analysis. In the "automation solutions" division, Stratec develops systems for the automation of laboratory processes. These are mainly used in clinical diagnostics to accelerate and simplify workflow. Examples include sample identification systems, pipetting robots, and analysis devices. In the "in vitro diagnostics" division, Stratec offers products for determining blood values. This includes devices for determining glucose, cholesterol, and hemoglobin levels, as well as devices for infection diagnostics and tumor and allergy diagnostics. Another division of Stratec is "microscopy." The company manufactures automated microscope systems, primarily used in biomedical research to analyze cells and tissues. In the "cell analysis" division, Stratec offers innovative methods for analyzing cells, such as cell growth and vitality determination. Stratec always focuses on tailoring the design of its products to the needs of its customers. High flexibility in device development and manufacturing is therefore an important factor in the company's success. In addition to device development and production, Stratec also provides services related to its products. These include installation, maintenance, and on-site repair of devices for customers. Stratec SE operates internationally and has branches in Europe, Asia, and America. The company employs over 1,000 people worldwide. Overall, Stratec SE is a successful and renowned provider of medical devices and systems for automating laboratory processes. With its diverse product portfolio and high flexibility in customer support, Stratec has earned a leading position in the industry. Stratec Se is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Stratec Se stock

Cash Conversion Cycle (CCC) of Stratec Se is 196.64 in 2025.

Cash Conversion Cycle (CCC) of Stratec Se changed from 260.36 to 196.64, representing a -24.47% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Cycle (CCC) Stratec Se since 2006 – with annual values, charts, and detailed analysis.

The Cash Conversion Cycle measures how long it takes to convert inventory investments into cash from sales. A shorter CCC indicates more efficient working capital management.

CCC = DSO + DIO - DPO

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Cycle (CCC)'s Stratec Se with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Cycle (CCC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Cycle (CCC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Stratec Se

All Key Metrics — Stratec Se